Colistimethate sodium is a polymyxin-class polypeptide antibiotic indicated for the treatment of serious infections caused by multidrug-resistant Gram-negative organisms, including Pseudomonas aeruginosa.… Read more









Colistimethate sodium is a polymyxin-class polypeptide antibiotic indicated for the treatment of serious infections caused by multidrug-resistant Gram-negative organisms, including Pseudomonas aeruginosa. As a prodrug, it functions by disrupting bacterial cell membranes to achieve bactericidal activity, serving as a critical therapeutic option when other antibiotics are ineffective. Pharmaceutical laboratories require high-quality reference standards and related compounds to support the rigorous quality control and analytical testing of this complex drug. This category provides essential materials, including reference standards for peak identification and specific impurities such as Colistin A and B derivatives, which are necessary for impurity profiling and method validation. These analytical standards enable accurate component characterization and ensure the precision of chromatographic methods, such as HPLC, required for maintaining product safety and compliance with regulatory pharmacopeial standards.